Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 4829-4839

  Staprans, Silvija I ^a,b,e   Dailey, Peter J ^c   Rosenthal, Ann ^d   Horton, Chris ^a   Grant, Robert M ^b   Lerche, Nicholas ^d   Feinberg, Mark B ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ARTICLE; DISEASE COURSE; HUMORAL IMMUNITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0033033882     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.4829-4839.1999     Document Type: Article

References (91)

1. Ahmad, A., and J. Menezes. 1996. Defective killing activity against gp120/ 41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals. AIDS 10:143-149.
2. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54-60.
3. Bentwich, Z., A. Kalinkovich, and Z. Weismnn. 1995. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 16:187-191.
4. Blaak, H., A. B. van't Wout, M. Brouwer, M. Cornelissen, N. A. Kootstra, N. Albrecht-van Lent, R. P. M. Keet, J. Goudsmit, R. A. Coutinho, and H. Schuitemaker. 1998. Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J. Virol. 72:218-224.
5. Blaxhult, A., F. Granath, K. Lidman, and J. Giesecke. 1990. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 4:125-129.
6. Buchbinder, S. P., T. Elbiek, E. Vittinghof, S. Staprans, and M. B. Feinberg. Unpublished data.
7. + T cells during an acute virus infection. Immunity 8:167-175.
8. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395-1402.
9. Carlson, J. R., T. P. McGraw, E. Keddie, J. L. Yee, A. Rosenthal, A. J. Langlois, R. Dickover, R. Donovan, P. A. Luciw, and M. B. Jennings. 1990. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 6:1239-1246.
10. Cox, D. 1972. Regression models and life-tables. J. R. Stat. Soc. Ser. B 34:187-220.
11. Dailey, P. J., M. Zamroud, R. Kelso, J. Kolberg, and M. Urdea. 1995. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected rhesus macaques using a branched DNA (bDNA) signal amplification assay. J. Med. Primatol. 24:209.
12. Daniel, M. D., R. C. Desrosiers, N. L. Letvin, N. W. King, D. K. Schmidt, P. Sehgal, and R. D. Hunt 1987. Simian models for AIDS. Cancer Detect. Prev. Suppl. 1:501-507.
13. Darby, S. C., D. W. Ewart, P. L. Giangrande, R. J. Spooner, and C. R. Rizza. 1996. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation. Lancet 347:1573-1579.
14. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, et al. 1995. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
15. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghof, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862. (Erratum, 274:1069.)
16. Desrosiers, R. C., J. D. Lifson, J. S. Gibbs, S. C. Czajak, A. Y. M. Howe, L. O. Arthur, and R. P. Johnson. 1998. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1431-1437.
17. Draper, N., and H. Smith. 1981. Applied regression analysis, 2nd ed, p. 1-55. John Wiley and Sons, New York, N.Y.
18. Folks, T., T. Rowe, F. Villinger, B. Parekh, A. Mayne, D. Anderson, H. McClure, and A. A. Ansari. 1997. Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques. J. Med. Primatol. 26:181-189.
19. Gardner, M., M. Endres, and P. Barry. 1994. The simian retroviruses: SIV and SRV, p. 133-277. In J. Levy (ed.), The Retroviridae, vol. 3. Plenum Press, New York, N.Y.
20. Gardner, M., A. Rosenthal, M. Jennings, J. Yee, L, Antipa, and E. Robinson, Jr. 1995. Passive immunization of rhesus macaques against SIV infection and disease. AIDS Res. Hum. Retroviruses 11:843-854.
21. Garred, P., J. Eugen-Olsen, A. K. Iversen, T. L. Benfield, A. Svejgaard, and B. Hofmann. 1997. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet 349:1884. (Letter.)
22. Grant, R M., and M. B. Feinberg. Unpublished data.
23. Harrell, F., and K. L. Lee. 1986. Verifying assumptions of the Cox proportional hazards model. In Proceedings of the 11th Annual SAS User's Group International Conference. SAS Institute, Cary, N.C.
24. Harrer, T., E. Harrer, S. A. Kalams, T. Elbeik, S. I. Staprans, M. B. Feinberg, Y. Cao, D. D. Ho, T. Yilma, A. M. Caliendo, R. P. Johnson, S. P. Buchbinder, and B. D. Walker. 1996. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses 12:585-592.
25. Hessol, N. A., B. A. Koblin, G. J. van Griensven, P. Bacchetti, J. Y. Liu, C. E. Stevens, R. A. Coutinho, S. P. Buchbinder, and M. H. Katz. 1994. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am. J. Epidemiol. 139:1077-1087.
26. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, Jr., W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
27. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. Ho, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
28. Jassoy, C., and B. D. Walker. 1997. HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication. Springer Semin. Immunopathol. 18: 341-354.
29. Joag, S. V., Z. Li, L. Foresman, D. M. Pinson, R. Raghavan, W. Zhuge, I. Adany, C. Wang, F. Jia, D. Sheffer, J. Ranchalis, A. Watson, and O. Narajan. 1997. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res. Hum. Retroviruses 13: 635-645.
30. + T cells and AIDS in pig-tailed macaques, J. Virol. 70:3189-3197.
31. Johnson, R. P., R. L. Glickman, J. Q. Yang, A. Kaur, J. T. Dion, M. J. Mulligan, and R. C. Desrosiers. 1997. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71:7711-7718.
32. + lymphocyte depletion in rhesus monkeys. J. Virol. 71:4218-4225.
33. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-I infection. Nat. Med. 2:405-411.
34. Kaur, A., R. M. Grant, R. E. Means, H. McClure, M. Feinberg, and R. P. Johnson. 1998. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72:9597-9611.
35. Kinloch-De Loes, S., B. J. Hirschel, B. Hoen, D. A. Cooper, B. Tindall, A. Carr, J. H. Saurat, N. Clumeck, A. Lazzarin, and L. Mathiesen. 1995. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N. Engl. J. Med. 333:408-413. (Erratum, 333:1367.)
36. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
37. Kostrikis, L. G., Y. Huang, J. P. Moore, S. M. Wolinsky, L. Zhang, Y. Guo, L. Deutsch, J. Phair, A. U. Neumann, and D. D. Ho. 1998. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat. Med. 4:350-353.
38. Koup, R. A., and D. D. Ho. 1994. Shutting down HIV. Nature 370:416.
39. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
40. Krowka, J. F., D. P. Stites, S. Jain, K. S. Steimer, C. George-Nascimento, A. Gyenes, P. J. Barr, H. Hollander, A. R Moss, and J. M. Homsy. 1989. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J. Clin. Investig. 83:1198-1203.
41. Kuroda, M. J., J. E. Schmitz, D. H. Barouch, A. Craiu, T. M. Allen, A Sette, D. L. Watkins, M. A. Forman, and N. L. Letvin. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1373-1381.
42. + T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules. J. Immunol. 159:2049-2057.
43. Letvin, N. L., M. D. Daniel, P. K. Sehgal, R. C. Desrosiers, R. D. Hunt, L. M. Waldron, J. J. MacKey, D. K. Schmidt, L. V. Chalifoux, and N. W. King. 1985. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230:71-73.
44. Lifson, J. D., M. A. Nowak, S. Goldstein, J. L. Rossio, A. Kinter, G. Vasquez, T. A. Wiltrout, C. Brown, D. Schneider, L. Wahl, A. L. Lloyd, J. Williams, W. R. Elkins, A. S. Fauci, and V. M. Hirsch. 1997. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71:9508-9514.
45. Liu, S.-L., T. Schacker, L. Musey, D. Shriner, M. J. McElrath, L. Corey, and J. I. Mullins. 1997. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71:4284-4295.
46. Marthas, M. L., K. K. A. Van Rompay, M. Otsyula, C. J. Miller, D. R. Canfield, N. C. Pedersen, and M. B. McChesney. 1995. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J. Virol. 69:4198-4205.
47. Martin, L. N., M. Murphey-Corb, K. F. Soike, B. Davison-Fairburn, and G. B. Baskin. 1993. Effects of initiation of 3′-azido,3′-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J. Infect. Dis. 168:825-835.
48. Martin, M. P., M. Dean, M. W. Smith, C. Winkler, B. Gerrard, N. L. Michael, B. Lee, R. W. Doms, J. Margolick, S. Buchbinder, J. J. Goedert, T. R. O'Brien. M. W. Hilgartner, D. Vlahov, S. J. O'Brien, and M. Carrington. 1998. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911.
49. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
50. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:945-954.
51. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsky. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170. (Erratum, 275:14, 1997.)
52. Michael, N. L., A. E. Brown, R. F. Voigt, S. S. Frankel, J. R. Mascola, K. S. Brothers, M. Louder, D. L. Birx, and S. A. Cassol. 1997. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection - evidence for highly susceptible human hosts. J. Infect. Dis. 175:1352-1359.
53. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
54. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M. J. McElrath. 1997. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267-1274.
55. mac. J. Virol. 62:4691-4696.
56. Nowak, M. A., A. L. Lloyd, G. M. Vasquez, T. A. Wiltrout, L. M. Wahl, N. Bischofberger, J. Williams, A. Kinter, A. S. Fauci, V. M. Hirsch, and J. D. Lifson. 1997. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71:7518-7525,
57. Operskalski, E. A., M. P. Busch, J. W. Mosley, and D. O. Strain. 1997. Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:145-150.
58. + count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:243-244. (Letter.)
59. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S. J. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, and B. Irvine. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:446-154.
60. Pantaleo, G., J. F. Demarest, T. Schacker, M. Vaccarezza, O. J. Cohen, M. Daucher, C. Graziosi, S. S. Schnittman, T. C. Quinn, G. M. Shaw, L. Perrin, G. Tambussi, A. Lazzarin, R. P. Sekaly, H. Soudeyns, L. Corey, and A. S. Fauci. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA 94:254-258.
61. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463-467.
62. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512.
63. Phillips, A. N. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271:497-499.
64. Reimann, K. A., J. T. Li, R Veazey, M. Halloran, L.-W. Park, G. B. Karlsson, J. Sodroski, and N. L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:6922-6928.
65. Reimann, K. A., K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. Yasutomi, W. Lin, B. J. Ransil, and N. L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370.
66. + T cell responses associated with control of viremia. Science 278:1447-1450.
67. Safrit, J. T., and R. A. Koup. 1995. The immunology of primary HIV infection: which immune responses control HIV replication? Curr. Opin. Immunol. 7:456-461.
68. Schacker, T., A. C. Collier, J. Hughes, T. Shea, and L. Corey. 1996. Clinical and Epidemiologic features of primary HIV infection. Ann. Intern. Med. 125:257-264. (Erratum, 126:174, 1997.)
69. Schacker, T. W., J. P. Hughes, T. Shea, R. W. Coombs, and L. Corey. 1998. Biological and virologie characteristics of primary HIV infection. Ann. Intern. Med. 128:613-620.
70. Schwartz, D. H., R. C. Castillo, S. Arango-Jaramillo, U. K. Sharma, H. F. Song, and G. Sridharan. 1997. Chemokine-independent in vitro resistance to human immunodeficiency virus (HIV-1) correlating with low viremia in long-term and recently infected HIV-1-positive persons. J. Infect. Dis. 176: 1168-1174.
71. Shapiro, S., and M. Wilk. 1965. An analysis of variance test for normality. Biometrika 52:591-611.
72. Shieh, T., D. Carter, K. Chadwick, J. Margolick, M. Zink, and J. Clements. 1998. Role of NK cells in control of acute SIV infection, abstr. 4085, p. 102. In Keystone Symposia on Molecular and Cellular Biology: HIV Pathogenesis and Treatment. Keystone Symposia, Drawer 1630, Silverthorne, Colo.
73. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Huttley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M. W. Hilgartner, and S. J. O'Brien. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277:959-965.
74. Sodora, D. L., F. Lee, P. J. Dailey, and P. A. Marx. 1998. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res. Hum. Retroviruses 14:171-181.
75. Staprans, S., B. Corliss, J. Guthrie, and M. B. Feinberg. 1996. Quantitative methods to monitor viral load in simian immunodeficiency virus infections, p. 167-184. In K. Adolph (ed.), Viral genome methods. CRC Press, Boca Raton, Fla.
76. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 182:1727-1737.
77. Suryanarayana, K., T. A. Wiltrout, G. M. Vasquez, V. M. Hirsch, and J. D. Lifson. 1998. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res. Hum. Retroviruses 14:183-189.
78. Ten Haaft, P., B. Verstrepen, K. Überla, B. Rosenwirth, and J. Heeney. 1998. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J. Virol. 72:10281-10285.
79. Trivedi, P., D. Horejsh, S. B. Hinds, P. W. Hinds II, M. S. Wu, M. S. Salvato, and C. D. Pauza. 1996. Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J. Virol. 70:6876-6883.
80. mne infection depends critically on timing of initiation and duration of treatment. J. Virol. 72:4265-4273.
81. Tsai, C. C., K. E. Follis, R. Grant, A. Sabo, R Nolte, C. Bartz, N. Bischofberger, and R. Benveniste. 1994. Comparison of the efficacy of AZT and PMEA treatment against acute SIVmne infection in macaques. J. Med. Primatol. 23:175-183.
82. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 270:1197-1199.
83. Valli, P. J. S., V. V. Lukashov, J. L. Heeney, and J. Goudsmit. 1998. Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage. J. Virol. 72:7494-7500.
84. Van Rompay, K. K. A., M. G. Otsyula, M. L. Marthas, C. J. Miller, M. B. McChesney, and N. C. Pedersen. 1995. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob. Agents Chemother. 39:25-131.
85. Watson, A., J. Ranchalis, B. Travis, J. McClure, W. Sutton, P. R. Johnson, S.-L. Hu, and N. L. Haigwood. 1997. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71:284-290.
86. + T cells is markedly enhanced in the setting of antigen-specific immune activation. J. Exp. Med. 183:687-692.
87. Winkler, C., W. Modi, M. W. Smith, G. W. Nelson, X. Wu, M. Carrington, M. Dean, T. Honjo, K. Tashiro, D. Yabe, S. Buchbinder, E. Vittinghoff, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R Detels, S. Donfield, A. Willoughby, E. Gomperts, D. Vlahov, J. Phair, and S. J. O'Brien. 1998. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HODS), Multicenter AIDS Cohort Study (MACS), Muiticenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279:389-393.
88. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J. Exp. Med. 185:1681-1691.
89. + cells in human immunodeficiency virus type 1 pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273-311.
90. Zaitseva, M., A. Blauvelt, S. Lee, C. K. Lapham, V. Klaus-Kovtun, H. Mostowski, J. Manischewitz, and H. Golding. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3:1369-1375.
91. Zhu, T., N. Wang, A. Carr, D. S. Nam, R. Moor-Jankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107.